Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

Mr. Matthew  Carbines B.Com., L.L.B.

General Counsel & Company Secretary

Mr. Matthew  Lipscombe B.E., B.Sc., M.B.A.

Chief Marketing Officer

Mr. Michael C. Kavanagh BSc, M.B.A.

Chief Executive Officer, President, MD & Executive Director

Ms. Jodi  Sampson M.B.A.

Chief People & Culture Officer

Mr. Keith  Koby BSEET, MBA

Senior Vice President of Sales - North America

Jason  Burriss

Chief Financial Officer

Dr. Steven  Farrugia B.E., Ph.D.

Chief Technology Officer

Mr. Rod  Lopez M.B.A.

Chief Operating Officer & Regional President for Asia Pacific

Mr. Vincent  Wang

Head of Global Customer Support & Technical Services

Mr. Sunny  Pillai

Chief Information Officer

Nome	Capitalizzazione di mercato
ConvaTec Group Plc	0M
Jiangsu Apon Medical Technology Co., Ltd.	0M
Bausch + Lomb Corporation	0M
SD BioSensor, Inc	0M
Ypsomed Holding AG	0M
InfuSystem Holdings, Inc.	0M
Sansure Biotech Inc.	0M
Menicon Co., Ltd.	0M
Alcon Inc.	0M
Nipro Corporation	0M
OrbusNeich Medical Group Holdings Limited	0M

Nanosonics Limited

Nanosonics Limited Elenco dei concorrenti

Principali concorrenti